As of Oct 23
| -2.43 / -1.33%|
The 24 analysts offering 12-month price forecasts for Amgen have a median target of 188.00, with a high estimate of 216.00 and a low estimate of 165.00. The median estimate represents a +4.14% increase from the last price of 180.53.
The current consensus among 28 polled investment analysts is to Hold stock in Amgen. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.